Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

被引：0
|
作者：
Jeremy Pettus
Schafer C. Boeder
Mark P. Christiansen
Douglas S. Denham
Timothy S. Bailey
Halis K. Akturk
Leslie J. Klaff
Julio Rosenstock
Mickie H. M. Cheng
Bruce W. Bode
Edgar D. Bautista
Ren Xu
Hai Yan
Dung Thai
Satish K. Garg
Samuel Klein
机构：
[1] University of California San Diego,Division of Endocrinology
[2] Diablo Clinical Research,Barbara Davis Center for Diabetes
[3] Clinical Trials of Texas,Center for Human Nutrition
[4] AMCR Institute,undefined
[5] University of Colorado Anschutz Campus,undefined
[6] Rainier Clinical Research Center,undefined
[7] Dallas Diabetes Research Center,undefined
[8] Marin Endocrine Care and Research,undefined
[9] Atlanta Diabetes Associates,undefined
[10] REMD Biotherapeutics,undefined
[11] Washington University School of Medicine,undefined
[12] St. Louis,undefined
[13] MO and Sansum Diabetes Research Institute,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2959 / 2959
相关论文
共 50 条
  • [31] Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial
    Pattzi, H. M. R.
    Pitale, S.
    Alpizar, M.
    Bennett, C.
    O'Farrell, A. M.
    Li, J.
    Cherrington, J. M.
    Guler, H. -P.
    DIABETES OBESITY & METABOLISM, 2010, 12 (04): : 348 - 355
  • [32] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED 12-WEEK TRIAL OF EPLIVANSERIN IN INSOMNIAC PATIENTS WITH SLEEP MAINTENANCE DIFFICULTIES
    Erman, M.
    Kryger, M.
    Soubrane, C.
    Morin, C.
    Hajak, G.
    SLEEP, 2009, 32 : A41 - A41
  • [33] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Burgos-Vargas, Ruben
    Loyola-Sanchez, Adalberto
    Ramiro, Sofia
    Reding-Bernal, Arturo
    Alvarez-Hernandez, Everardo
    van der Heijde, Desiree
    Vazquez-Mellado, Janitzia
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [34] A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis
    Rubén Burgos-Vargas
    Adalberto Loyola-Sanchez
    Sofia Ramiro
    Arturo Reding-Bernal
    Everardo Alvarez-Hernandez
    Desirée van der Heijde
    Janitzia Vázquez-Mellado
    Arthritis Research & Therapy, 24
  • [35] A 12-Week Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topiramate for the Treatment of Compulsive Buying Disorder
    de Mattos, Cristiana
    Kim, Hyoun S.
    Marasaldi, Renata F.
    Requiao, Marinalva G.
    de Oliveira, Elen Cristina
    Filomensky, Tatiana
    Tavares, Hermano
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (02) : 186 - 190
  • [36] Icosabutate for the treatment of very high triglycerides: A placebo-controlled, randomized, double-blind, 12-week clinical trial
    Bays, Harold E.
    Hallen, Jonas
    Vige, Runar
    Fraser, David
    Zhou, Rong
    Hustvedt, Svein Olaf
    Orloff, David G.
    Kastelein, John J. P.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : 181 - 191
  • [37] Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
    Hirose, Takahisa
    Suzuki, Manabu
    Tsumiyama, Isao
    DIABETES THERAPY, 2015, 6 (04) : 559 - 571
  • [38] Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
    Takahisa Hirose
    Manabu Suzuki
    Isao Tsumiyama
    Diabetes Therapy, 2015, 6 : 559 - 571
  • [39] Botulinum toxin type A in migraine without aura prophylaxis; a 12-week prospective, multicentre, double-blind, randomized, placebo-controlled trial
    Chankrachang, S
    Arayawichanont, A
    Poungvarin, N
    Nidhinandana, S
    Boonkongchuen, P
    Towanabut, S
    Sithinamsuwan, P
    Kongsaengdao, S
    CEPHALALGIA, 2005, 25 (10) : 992 - 993
  • [40] A 12-week, randomized, double-blind, placebo-controlled, four-arm dose-finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes
    Halvorsen, Yuan-Di
    Walford, Geoffrey
    Thurber, Tara
    Russell, Heidy
    Massaro, Monica
    Freeman, Mason W.
    DIABETES OBESITY & METABOLISM, 2020, 22 (04): : 566 - 573
12345